|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61B 5/154 | (2006.01) |
| A61B 5/15003 | (2013.01) | ||
| A61B 5/15 | (2006.01) | ||
| A61B 5/150755 | (2013.01) | ||
| A61B 5/154 | (2013.01) | ||
| B01L2200/16 | (2013.01) | ||
| B01L 3/5082 | (2013.01) |
| (11) | Number of the document | 3334343 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16757774.1 |
| Date of filing the European patent application | 2016-08-12 | |
| (97) | Date of publication of the European application | 2018-06-20 |
| (45) | Date of publication and mention of the grant of the patent | 2022-10-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/046681 |
| Date | 2016-08-12 |
| (87) | Number | WO 2017/027771 |
| Date | 2017-02-16 |
| (30) | Number | Date | Country code |
| 201562204644 P | 2015-08-13 | US | |
| 201562214308 P | 2015-09-04 | US |
| (72) |
SEXTON, Daniel, J. , US
FAUCETTE, Ryan , US
|
| (73) |
Takeda Pharmaceutical Company Limited ,
1-1, Doshomachi 4-chome,
Chuo-ku,, Osaka-shi, Osaka,
JP
|
| (54) | EVACUATED BLOOD COLLECTION TUBES CONTAINING PROTEASE INHIBITORS FOR THE ASSESSMENT OF CONTACT SYSTEM ACTIVATION |
| EVACUATED BLOOD COLLECTION TUBES CONTAINING PROTEASE INHIBITORS FOR THE ASSESSMENT OF CONTACT SYSTEM ACTIVATION |